RxDoctor Payments Data

Swarupa Gadre, MD

Anatomic Pathology & Clinical Pathology · Jeffersonville, INNPI 1538295506

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 13 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Myriad Genetic Laboratories, Inc. at 45.5% of the total.

$478in general payments, 2019–2025

Across 13 payments — averaging $36.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Myriad Genetic Laboratories, Inc.$218
  • Medtronic$108
  • Blue Earth Diagnostics$48
  • Boston Scientific$36
  • Procept Biorobotics Corporation$31
  • Endo Pharmaceuticals Inc.$24
  • plus $13 from 1 others

What the payments were for

  • Food & beverage$478100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$478 in reported general payments places this provider in the 85th percentile of 137 anatomic pathology & clinical pathology providers in Indiana.

See all anatomic pathology & clinical pathology providers in Indiana

Medicare billing

Part B allowed, 2024
$429,909
Medicare patients
1,441
Services billed
2,686

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in Jeffersonville

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →